Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als symbols : NVS save search
Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
Published: 2022-03-15 (Crawled : 21:00) - globenewswire.com
MOLN | $3.88 190
|
Professional, Scientific, and T...
|
| O: -0.2%
H: 0.24%
C: -0.46%
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
als report molecular
Radiopharmaceuticals Market Size to Grow by USD 4.37 Bn| 44% of the growth to originate from North America| Technavio
Published: 2022-03-14 (Crawled : 12:00) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -3.28%
H: 0.0%
C: 0.0%
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
FUSN | $21.4 -0.09% 180K
|
Health Technology
|
| O: -0.14%
H: 0.34%
C: 0.34%
america als origin growth
Dermatologicals Market to Reach $59.30 Bn, Globally, by 2030 at 11.50% CAGR: AMR
Published: 2022-02-21 (Crawled : 13:30) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.515 -0.7% 4.3M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.905 -0.81% 890K
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $274.15 0.22% 900K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 2.6K
|
Health Technology
| Email alert
Add to watchlist
als dermatological derm
Bronchoscopes Market is Anticipated to Surge at a CAGR of 7.43% and is Also Contemplated to Reach USD 27.48 Billion by 2026, Analyzes DelveInsight
Published: 2022-02-04 (Crawled : 17:00) - prnewswire.com
TFX | $212.17 0.5% 83K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
SYK | $337.39 0.74% 880K
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
MDT | $80.37 -1.13% 2.6M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
GSK | News | $40.905 -0.81% 890K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
BSX | $73.295 6.24% 8.1M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
BDX | $233.97 -0.17% 420K
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
als
Non-alcoholic Steatohepatitis Clinical Trials Market Size Worth $4.2 Billion By 2030: Grand View Research, Inc.
Published: 2022-02-01 (Crawled : 11:00) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -1.59%
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
ICLR | News | $307.985 0.5% 480K
|
Health Technology
|
| O: 0.89%
H: 0.59%
C: 0.41%
hepatitis als trials research trial clinical trials
Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity of Gilenya® (fingolimod) dosage regimen patent
Published: 2022-01-04 (Crawled : 07:00) - globenewswire.com
NVS | News | $98.1 0.84% 1.3M
|
Health Technology
|
| O: 0.17%
H: 0.12%
C: -0.62%
gilenya novartis als patent
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.87 59.83% 100M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.